JusticeItaly Official institution
Italy authorizes Pirfenidone Vivanta tablets
Italy's medicines agency AIFA has authorized Pirfenidone Vivanta, a generic lung medicine, for sale in Italy. The decision is dated 29 September 2026 and was published on 6 November 2026. Vivanta Generics S.R.O. of Prague holds the license.
This summary was generated by AI; the official source prevails.
What does it mean?
Pirfenidone Vivanta is now approved to be sold in Italy as tablets. Doctors who treat lung conditions, mainly lung specialists, can prescribe it, and patients will need a new prescription each time they refill it.
Who is affected?
Patients with lung conditions who may be prescribed the medicine, and the specialists who prescribe it.